Home / Import refusals / SCS-7987432-0/11/1

FDA Import Refusal SCS-7987432-0/11/1 — Merck And Co Inc

Merck And Co Inc — FEI 3005421743

The FDA refused shipment SCS-7987432-0/11/1 from Merck And Co Inc (United States) on June 20, 2023. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 20, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
61PBY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
Charges
75

Other import refusals

  • AEK-9254299-0/10001/1 (Wed Jan 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7515529-9/10002/1 (Wed Aug 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7462726-4/30001/1 (Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-6705454-8/91/1 (Fri Nov 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5766294-0/11/1 (Sat Nov 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources